Hematicus Limited Partnership is categorized under Ultrasonic Scanning Devices, Medical in Sugar Land, TX and active since 2001.
Hematicus Limited Partnership was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Ultrasonic Scanning Devices, Medical business, which does work in the B2B market, and is classified as a Ultrasonic Scanning Devices, Medical, under code number 334510 by the NAICS.
If you are seeking more information, feel free to contact Paul G Loubser at the company’s single location by writing to 302 Lakeglen Court, Sugar Land, Texas TX 77478 or by phoning (281) 242-3060. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Hematicus Limited Partnership |
| Contact Person: | Paul G Loubser |
| Address: | 302 Lakeglen Court, Sugar Land, Texas 77478 |
| Phone Number: | (281) 242-3060 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Ultrasonic Scanning Devices, Medical |
| SIC Code: | 3845 |
| NAICS Code: | 334510 |
| Share This Business: |
Hematicus Limited Partnership was started in 2001 to provide professional Ultrasonic Scanning Devices, Medical under the SIC code 3845 and NAICS code 334510. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Paul G Loubser for inquiries that concern Hematicus Limited Partnership by calling the company number (281) 242-3060, as your correspondence is most welcome. Additionally, the physical location of the single location of Hematicus Limited Partnership can be found at the coordinates 29.610888,-95.607382 as well as the street address 302 Lakeglen Court in Sugar Land, Texas 77478.
For its online presence, you may visit Hematicus Limited Partnership’s website at and engage with its social media outlets through on Twitter and on Facebook.